Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250990 · ClinicalTrials.gov registry record · NA
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01250990: Completed NA study, sponsored by University of Pennsylvania.
NCT01250990 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01250990, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study looks at whether niacin improves reverse cholesterol transport (RCT) in healthy volunteers. 3H-Cholesterol will be used to measure RCT by analyzing changes in the tracer activity in total plasma, lipoproteins, red blood cells (RBCs) and stool. The hypothesis is that niacin augments reverse cholesterol transport.
Interventions
- DRUG Niacin
- OTHER Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01250990
The ClinicalTrials.gov registry entry for NCT01250990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Niacin is the first listed.
NCT01250990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01250990 about?
NCT01250990 is a clinical study titled "Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis". This study looks at whether niacin improves reverse cholesterol transport (RCT) in healthy volunteers. 3H-Cholesterol will be used to measure RCT by analyzing changes in the tracer activity in total plasma, lipoproteins, red blood cells (RBCs) and stool. The hypothesis is that niacin augments revers...
What is the current status of trial NCT01250990?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2010-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01250990?
The interventions under investigation include: Niacin (DRUG), Placebo (OTHER).
Who is sponsoring clinical trial NCT01250990?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.